• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Verastem, Inc. - Common Stock (NQ:VSTM)

    7.270 -0.240 (-3.20%)
    Streaming Delayed Price Updated: 10:37 AM EDT, Sep 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Verastem, Inc. - Common Stock

    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 Next >
    News headline image
    Verastem Oncology to Present at Upcoming Investor Conferences
    From Verastem Oncology
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3... 
    Via Benzinga
    News headline image
    Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini Oral Presentation at the European Society of Medical Oncology Congress 2021
    From Verastem Oncology
    Via Business Wire
    Why Verastem's Stock Is Trading Higher Today ↗
    Verastem (NASDAQ:VSTM) shares are trading higher... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million.... 
    Via Benzinga
    News headline image
    Verastem Oncology Announces Conversion of Senior Notes Eliminating Substantially All Outstanding Debt
    From Verastem Oncology
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life... 
    Via Benzinga
    News headline image
    Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Verastem Oncology
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021 ↗
    Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE: 
    Via Benzinga
    News headline image
    Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
    From Verastem Oncology
    Via Business Wire
    News headline image
    44 Biggest Movers From Yesterday ↗
    Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its... 
    Via Benzinga
    News headline image
    2 Biotech Penny Stocks That Are Vastly Superior Investments to Dogecoin ↗
    These unloved cancer stocks should dramatically outperform Dogecoin over the long haul. 
    Via The Motley Fool
    News headline image
    Stocks That Hit 52-Week Highs On Wednesday ↗
    Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs. Interesting Facts: Toyota Motor (NYSE:TM) was the largest firm by market cap to set a new 52-... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Gainers NeuroMetrix (NASDAQ:NURO) stock r... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Highs On Monday ↗
    During Monday's morning session, 255 companies made new 52-week highs. Points of Interest: The largest company by market cap to set a new 52-week high was Adobe (... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Highs On Wednesday ↗
    During Wednesday's morning trading, 251 companies set new 52-week highs. Areas of Interest: Alphabet (NASDAQ:GOOG) was the company with the largest market cap... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Highs On Tuesday ↗
    Tuesday morning saw 244 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Highs On Friday ↗
    Before 10 a.m. ET Friday, 188 stocks made new 52-week highs. Things to Consider: The largest company by market cap to set a new 52-week high was Coca-Cola (NYSE:KO... 
    Via Benzinga
    News headline image
    Verastem Oncology to Present at the 2021 Jefferies Virtual Healthcare Conference
    From Verastem, Inc.
    Via Business Wire
    News headline image
    The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... 
    Via Benzinga
    News headline image
    Why Verastem Stock Is Crushing It Today ↗
    The biotech's experimental cancer treatment won an important regulatory designation today. 
    Via The Motley Fool
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 101.34% to $12.0 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 17.5... 
    Via Benzinga
    News headline image
    52 Biggest Movers From Yesterday ↗
    Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,... 
    Via Benzinga
    News headline image
    Verastem's VS-6766/Defactinib Combo Gets Breakthrough Therapy Tag For Ovarian Cancer; BTIG Upgrades Stock ↗
    The FDA has granted Breakthrough Therapy designation to Verastem Inc (NASDAQ: VSTM) for the combination of its investigational VS-6766, with defactinib,... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Highs On Monday ↗
    This morning 128 companies set new 52-week highs. Points of Interest: Novo Nordisk (NYSE:NVO) was the biggest firm by market cap to hit a new 52-week high. Taylor... 
    Via Benzinga
    News headline image
    Verastem Oncology Receives Breakthrough Therapy Designation for VS-6766 with Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
    From Verastem, Inc.
    Via Business Wire
    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.